REFERENCES
1. Steinberg GR, Valvano CM, De Nardo W, Watt MJ. Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms. J Hepatol. 2025;83:584-95.
2. Park Y, Ko KS, Rhee BD. Non-alcoholic fatty liver disease (NAFLD) management in the community. Int J Mol Sci. 2025;26:2758.
3. Wang X, Zhang L, Dong B. Molecular mechanisms in MASLD/MASH-related HCC. Hepatology. 2025;82:1303-24.
4. Do A, Zahrawi F, Mehal WZ. Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH). Nat Rev Drug Discov. 2025;24:171-89.
5. Brisnovali NF, Haney C, Goedeke L. RezdiffraTM (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis. Trends Pharmacol Sci. 2024;45:1081-2.
6. Sanyal AJ, Newsome PN, Kliers I, et al. ; ESSENCE Study Group. Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis. N Engl J Med. 2025;392:2089-99.
7. Shah VN, Akturk HK, Kruger D, et al. Semaglutide in adults with type 1 diabetes and obesity. NEJM Evid. 2025;4:EVIDoa2500173.
8. Jara M, Norlin J, Kjær MS, et al. Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis. Nat Med. 2025;31:3128-40.
9. Tilg H, Adolph TE, Dudek M, Knolle P. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nat Metab. 2021;3:1596-607.
10. Safari Z, Gérard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci. 2019;76:1541-58.
11. Tran S, Baba I, Poupel L, et al. Impaired kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis. Immunity. 2020;53:627-40.e5.
12. Park SJ, Garcia Diaz J, Um E, Hahn YS. Major roles of kupffer cells and macrophages in NAFLD development. Front Endocrinol. 2023;14:1150118.
13. Zhao B, Lin H, Jiang X, et al. Exosome-like nanoparticles derived from fruits, vegetables, and herbs: innovative strategies of therapeutic and drug delivery. Theranostics. 2024;14:4598-621.
14. Li Y, Wang Y, Zhao H, Pan Q, Chen G. Engineering strategies of plant-derived exosome-like nanovesicles: current knowledge and future perspectives. Int J Nanomedicine. 2024;19:12793-815.
15. Bai C, Liu J, Zhang X, et al. Research status and challenges of plant-derived exosome-like nanoparticles. Biomed Pharmacother. 2024;174:116543.
16. Chen H, Ding Q, Li L, et al. Extracellular vesicle spherical nucleic acids. JACS Au. 2024;4:2381-92.
17. Cai Q, He B, Wang S, et al. Message in a bubble: shuttling small rnas and proteins between cells and interacting organisms using extracellular vesicles. Annu Rev Plant Biol. 2021;72:497-524.
18. Zeng Y, Yu S, Lu L, Zhang J, Xu C. Ginger-derived nanovesicles attenuate osteoarthritis progression by inhibiting oxidative stress via the Nrf2 pathway. Nanomedicine. 2024;19:2357-73.
19. Zhang M, Viennois E, Prasad M, et al. Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016;101:321-40.
20. Zhuang X, Deng ZB, Mu J, et al. Ginger-derived nanoparticles protect against alcohol-induced liver damage. J Extracell Vesicles. 2015;4:28713.
21. Kumar A, Sundaram K, Teng Y, et al. Ginger nanoparticles mediated induction of Foxa2 prevents high-fat diet-induced insulin resistance. Theranostics. 2022;12:1388-403.
22. Wang M, Chen J, Chen W, et al. Grape-derived exosome-like nanovesicles effectively ameliorate skin photoaging by protecting epithelial cells. J Food Sci. 2025;90:e70309.
23. Jung D, Kim NE, Kim S, et al. Plant-derived nanovesicles and therapeutic application. Pharmacol Ther. 2025;269:108832.
24. Di Gioia S, Hossain MN, Conese M. Biological properties and therapeutic effects of plant-derived nanovesicles. Open Med. 2020;15:1096-122.
25. Tiwari A, Soni N, Dongre S, Chaudhary M, Bissa B. The role of plant-derived extracellular vesicles in ameliorating chronic diseases. Mol Biol Rep. 2025;52:360.
26. Xie H, Su D, Zhang J, et al. Raw and vinegar processed Curcuma wenyujin regulates hepatic fibrosis via bloking TGF-β/Smad signaling pathways and up-regulation of MMP-2/TIMP-1 ratio. J Ethnopharmacol. 2020;246:111768.
27. Wang L, Li X, Wang Y, et al. Rapid discrimination and screening of volatile markers for varietal recognition of Curcumae Radix using ATR-FTIR and HS-GC-MS combined with chemometrics. J Ethnopharmacol. 2021;280:114422.
28. Dong J, Shao W, Yan P, et al. Curcumolide, a unique sesquiterpenoid with anti-inflammatory properties from Curcuma wenyujin. Bioorg Med Chem Lett. 2015;25:198-202.
29. Li Y, Wu Y, Li Y, Guo F. Review of the traditional uses, phytochemistry, and pharmacology of Curcuma wenyujin Y. H. Chen et C. Ling. J Ethnopharmacol. 2021;269:113689.
30. Brown GT, Kleiner DE. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism. 2016;65:1080-6.
31. Bond A, Morrissey MA. Biochemical and biophysical mechanisms macrophages use to tune phagocytic appetite. J Cell Sci. 2025;138:JCS263513.
32. Naeini MB, Bianconi V, Pirro M, Sahebkar A. The role of phosphatidylserine recognition receptors in multiple biological functions. Cell Mol Biol Lett. 2020;25:23.
33. Yan G, Xiao Q, Zhao J, et al. Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy. J Control Release. 2024;367:425-40.
34. Ding T, Li W, Li F, Ren M, Wang W. microRNAs: key regulators in plant responses to abiotic and biotic stresses via endogenous and Cross-Kingdom mechanisms. Int J Mol Sci. 2024;25:1154.
35. Luo Y, Zhu L, Ren Z, et al. Curcumae Rhizoma: an anti-cancer traditional Chinese medicine. Chin Herb Med. 2025;17:428-47.
36. Yin GP, Li LC, Zhang QZ, et al. iNOS inhibitory activity of sesquiterpenoids and a monoterpenoid from the rhizomes of Curcuma wenyujin. J Nat Prod. 2014;77:2161-9.
37. Liu ZL, Zhao NN, Liu CM, Zhou L, Du SS. Identification of insecticidal constituents of the essential oil of Curcuma wenyujin rhizomes active against Liposcelis bostrychophila Badonnel. Molecules. 2012;17:12049-60.
38. Chu C, Yu L, Wu B, et al. A sequence of 28S rRNA-derived small RNAs is enriched in mature sperm and various somatic tissues and possibly associates with inflammation. J Mol Cell Biol. 2017;9:256-9.
39. Gu X, Zhu D, Li Y, et al. Identification of plasma rRNA-derived small RNA biomarkers for diagnosis of colorectal cancer. Mol Carcinog. 2025;64:1580-90.
